Health care workers and tuberculosis

Australian and New Zealand Journal of Medicine

Volumn 30, Issue 3, 2000, Pages 367-372

  Stuart, Rhonda L ^a,b   Grayson, M L ^a  

^a MONASH MEDICAL CENTRE   (Australia)

^b ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; ISONIAZID;

BCG VACCINATION; CHEMOPROPHYLAXIS; HEALTH CARE PERSONNEL; HUMAN; INCIDENCE; INFECTION CONTROL; INFECTION RISK; MYCOBACTERIUM TUBERCULOSIS; OCCUPATIONAL HAZARD; REVIEW; TUBERCULIN TEST; TUBERCULOSIS;

EID: 0033923625     PISSN: 00048291     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2000.tb00839.x     Document Type: Review

References (45)

1. 1. Bloom BR, Murray JL. Tuberculosis: Commentary on a re-emergent killer. Science 1992; 257.
2. 2. Sepkowitz KA, Friedman CR, Hafner A, Kwok D, Manoach S, Floris M et al. Tuberculosis among urban health care workers: A study using restriction fragment length polymorphism typing. Clin Infect Dis 1995; 21: 1098-102.
3. 3. Sepkowitz KA. Tuberculosis and the health care worker: An historical perspective. Ann Intern Med 1994; 120: 71-9.
4. 4. Daniels M, Ridehalgh F, Springett VH, Hall IM. Tuberculosis in young adults: Report on the Prophit tuberculosis survey, 1936-1944. London: H.K. Lewis and Co, Ltd, 1948.
5. 5. Stewart DA. The general hospital and tuberculous patients. Trans Am Med Assoc 1931; 463-5.
6. 6. Heimbeck J. Tuberculosis in hospital nurses. Tubercle 1936; 18: 97-9.
7. 7. Israel HL, Hetherington H, Ord JG. A study of tuberculosis among students of nursing. JAMA 1942; 117: 839-44.
8. 8. Dufault P. Tuberculous infection among nurses and medical students in sanatoriums and general hospitals. N Engl J Med 1941; 224: 711-5.
9. 9. Centers for Disease Control. Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in health care facilities. MMWR 1994; 43 (RR-13): 1-132.
10. 10. Edwards PQ, Edwards LB. The story of the tuberculin test. Am Rev Respir Dis 1960; 81: 1-45.
11. 11. Menzies R, Vissandjee B. Effect of Bacille Calmette-Guerin vaccination on tuberculin reactivity. Am Rev Respir Dis 1992; 145: 621-5.
12. 12. Stuart R, Turnidge J, Grayson M. Mantoux testing in health care workers (HCWs). Are the current guidelines appropriate? Clin Infect Dis 1996; 23: 888.
13. 13. Fitzgerald JM, Gafni A. A cost-effectiveness analysis of the routine use of isoniazid prophylaxis in patients with a positive mantoux skin test. Am Rev Respir Dis 1990; 142: 848-53.
14. 14. Ramphal-Naley L, Kirkhorn S, Lohman WH, Zelterman D. Tuberculosis in physicians: compliance with surveillance and treatment. Am J Infect Control 1996; 24: 243-53.
15. 15. Nettleman MD, Geerdes H, Roy M-C. The cost-effectiveness of preventing tuberculosis in physicians using tuberculin skin testing or a hypothetical vaccine. Arch Intern Med 1997; 157: 1121-7.
16. 16. Heimbeck J. Immunity to tuberculosis. Arch Intern Med 1928; 41: 336-42.
17. 17. Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, Fineberg HV et al. Efficacy of BCG vaccine in the prevention of tuberculosis. JAMA 1994; 271: 698-702.
18. 18. Brewer TF, Colditz GA. Bacille Calmette-Guerin Vaccination for the prevention of tuberculosis in health care workers. Clin Infect Dis 1995; 20: 136-42.
19. 19. Rosenthal S. Standardization and efficacy of BCG vaccination against tuberculosis - Twenty year study: A critical evaluation. JAMA 1955; 157: 801-7.
20. 20. Abruzzi W, Hummel R. Tuberculosis: incidence among American medical students, prevention and control and the use of BCG. N Engl J Med 1953; 248: 722-9.
21. 21. Geiseler PJ, Nelson KE, Crispen RG, Moses VK. Tuberculosis in physicians: A continuing problem. Am Rev Respir Dis 1986; 133: 773-8.
22. 22. Greenberg P, Lax K, Schechter C. Tuberculosis in house staff. A decision analysis comparing the tuberculin screening strategy with the BCG vaccination. Am Rev Respir Dis 1991; 143: 490-5.
23. 23. Reichman LB, Mangura BT. Use of Bacille Calmette-Guerin vaccine in health care workers. Clin Infect Dis 1996; 22: 392.
24. 24. National Health and Medical Research Council. The Australian Immunisation Handbook. 6th edn. Canberra: Australian Government Publishing Service, 1997.
25. 25. Mount F, Ferebee S. The effect of isoniazid prophylaxis on tuberculosis morbidity among household contacts of previously known cases of tuberculosis. Am Rev Resp Dis 1962; 85: 821-7.
26. 26. Ferebee SH. Controlled chemoprophylaxis trials in tuberculosis - A general review. Adv Tuberc Res 1970; 17: 28-106.
27. 27. McAnulty JM, Fleming DW, Hawley M-A, Baron RC. Missed opportunities for tuberculosis prevention. Arch Intern Med 1995; 155: 713-6.
28. 28. Kucers A, Crowe S, Grayson M, Hoy J. The use of antibiotics: a clinical review of antibacterial, antifungal and antiviral drugs. 5th edn. London: Butterworth-Heinemann, 1997.
29. 29. Millard PS, Wilcosy TC, Reade-Christopher SJ, Weber DJ. Isoniazid-related fatal hepatitis. West J Med 1996; 164: 486-91.
30. 30. Stuart RL, Wilson J, Grayson ML. Isoniazid toxicity in health care workers. Clin Infect Dis 1999; 28: 895-7.
31. 31. American Thoracic Society. Treatment of tuberculosis and tuberculosis infection in adults and children. Clin Infect Dis 1995; 21: 9-27.
32. 32. Barret-Connor E. The epidemiology of tuberculosis in physicians. JAMA 1979; 241: 33-8.
33. 33. Geiseler PJ, Nelson KE, Crispen RG. Tuberculosis in physicians. Compliance with preventive measures. Am Rev Respir Dis 1987; 135: 3-9.
34. 34. McGowan JE. Resurgent nosocomial tuberculosis: consequences and actions for hospital epidemiologists. Infect Control Hosp Epidemiol 1992; 13: 575-8.
35. 35. Jarvis WR. Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis. A J Infect Control 1995; 23: 146-51.
36. 36. Bailey TC, Fraser VJ, Spitnagel EL, Dunagan WC. Risk factors for a positive tuberculin skin test among employees of an urban, midwestern teaching hospital. Ann Intern Med 1995; 122: 580-5.
37. 37. Blumberg HM, Watkins DL, Berschling JD, Antle A, Moore P, White N et al. Preventing the nosocomial transmission of tuberculosis. Ann Intern Med 1995; 122: 658-63.
38. 38. Fridkin SK, Managangan L, Bolyard E, America TSfHEo, Jarvis WR. SHEA-CDC TB Survey, Part 2: Efficacy of TB infection control programs at member hospitals, 1992. Infect Control Hosp Epidemiol 1995; 16: 135-40.
39. 39. Schwartzman K, Loo V, Pasztor J, Menzies D. Tuberculosis infection among health care workers in Montreal. Am J Respir Crit Care Med 1996; 154: 1006-12.
40. 40. Sepkowitz KA, Fella P, Rivera P, Villa N, DeHovitz J. Prevalence of PPD positivity among new employees at a hospital in New York City. Infect Control Hosp Epidemiol 1995; 16: 344-7.
41. 41. Gilroy N, Oliver G, Harvey B. Tuberculosis notifications in Australia, 1996. Commun Dis Intell 1998; 22: 173-83.
42. 42. Raviglione M, Snider D, Kochi A. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA 1995; 273: 220-6.
43. 43. Dawson D. Tuberculosis in Australia: bacteriologically confirmed cases and drug resistance, 1996. Commun Dis Intell 1998; 22: 183-7.
44. 44. Stuart R, Bennett N, Hart W, Johnson P, Grayson ML. Mantoux testing of health care workers - The Melbourne Mantoux study. Aust NZ J Med 1998; 25: 712.
45. 45. Victorian Department of Human Services. Management, Control and Prevention of Tuberculosis. Guidelines for Health Care Providers, 1997.